The COVID-19 pandemic has resulted in children spending more time on digital devices, which may have a long-term impact on their vision, including the risk of myopia.
Contact lens technology is reaching the point where science fiction meets reality. From interfaces to pressure monitors and drug release features, the contact lens industry is about to be disrupted.
Knowing genetic associations in specific populations will make it possible to focus prevention and treatment on those who will benefit most, sparing expense and side effects from those who will not.
When you head out onto the road, there’s always a chance that you might encounter a driver who has a vision problem, putting his or her driving at risk. Regulations need to change.
Glaucoma is a serious disease which, if left untreated, can cause blindness. A professor of optometry explains the risks, process of diagnosis and available treatments.
Insurance companies sometimes try to cut costs by substituting less expensive drugs for a specific drug prescription. That’s raising problems in many cases, and actually causing harm.
There is value in including different populations in genetic research studies as has been shown in a study on exfoliation syndrome, which leads to glaucoma.
Glaucoma is the sneak thief of sight, affecting the eyesight of more than 50 million people worldwide. It remains the biggest preventable cause of blindness today.
Scientists have discovered that the high pressure in the eye that occurs with most common forms of glaucoma can trigger two genes that work together to cause vision loss, which may help pave the way for new glaucoma drugs.
Scientists have proposed a way to monitor glaucoma using a tiny device implanted in the eye. Readings from the device could be monitored by a smartphone. The technology could help prevent some people from…
Melbourne Laureate Professor, Harold Mitchell Chair of Indigenous Eye Health, Melbourne School of Population and Global Health, The University of Melbourne